Zylox-Tonbridge Medical Technology Co., Ltd. (2190.HK)
- Previous Close
10.240 - Open
10.400 - Bid 10.300 x --
- Ask 10.340 x --
- Day's Range
10.100 - 10.560 - 52 Week Range
7.200 - 14.660 - Volume
64,500 - Avg. Volume
223,054 - Market Cap (intraday)
3.385B - Beta (5Y Monthly) 0.42
- PE Ratio (TTM)
-- - EPS (TTM)
-0.260 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
15.63
Zylox-Tonbridge Medical Technology Co., Ltd., a medical device company, provides neuro- and peripheral-vascular interventional medical devices the People's Republic of China and internationally. The company develops neurovascular product portfolio that covers a suite of products for various categories, including ischemic stroke, hemorrhagic stroke, intracranial stenosis, carotid artery, and intracranial access devices. It also develops peripheral-vascular interventional product portfolio covering a spectrum of arterial and venous products comprising stents, balloons, catheters, and filters, as well as covers hemodialysis access, aortic intervention, peripheral embolization intervention, and radiological intervention products. In addition, the company provides technical consultation and services; as well as imports materials. The company was formerly known as Zhejiang Zylox Medical Device Co., Ltd. and changed its name to Zylox-Tonbridge Medical Technology Co., Ltd. in March 2021. Zylox-Tonbridge Medical Technology Co., Ltd. was incorporated in 2012 and is headquartered in Hangzhou, the People's Republic of China.
www.zyloxtb.comRecent News: 2190.HK
Performance Overview: 2190.HK
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 2190.HK
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 2190.HK
Valuation Measures
Market Cap
3.39B
Enterprise Value
1.81B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
5.96
Price/Book (mrq)
1.03
Enterprise Value/Revenue
3.43
Enterprise Value/EBITDA
-23.40
Financial Highlights
Profitability and Income Statement
Profit Margin
-14.92%
Return on Assets (ttm)
-2.95%
Return on Equity (ttm)
-2.56%
Revenue (ttm)
527.75M
Net Income Avi to Common (ttm)
-78.73M
Diluted EPS (ttm)
-0.260
Balance Sheet and Cash Flow
Total Cash (mrq)
1.51B
Total Debt/Equity (mrq)
1.83%
Levered Free Cash Flow (ttm)
--
Research Analysis: 2190.HK
Analyst Price Targets
Fair Value
No Fair Value available for this ticker
Company Insights: 2190.HK
2190.HK does not have Company Insights